As of 2025-05-26, the Intrinsic Value of Bright Minds Biosciences Inc (DRUG.CN) is -0.76 CAD. This DRUG.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 39.78 CAD, the upside of Bright Minds Biosciences Inc is -101.91%.
Based on its market price of 39.78 CAD and our intrinsic valuation, Bright Minds Biosciences Inc (DRUG.CN) is overvalued by 101.91%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.76 - -0.76 | -0.76 | -101.91% |
| P/E | 39.78 - 39.78 | 39.78 | -0.0% |
| DDM - Stable | (0.06) - (0.09) | (0.07) | -100.2% |
| DDM - Multi | (0.04) - (0.06) | (0.05) | -100.1% |
| Market Cap (mil) | 280.05 |
| Beta | 44.54 |
| Outstanding shares (mil) | 7.04 |
| Enterprise Value (mil) | 222.34 |
| Market risk premium | 5.10% |
| Cost of Equity | 172.67% |
| Cost of Debt | 5.00% |
| WACC | 172.60% |